EXPERIENCE WITH VORASIDENIB IN PATIENTS WITH GRADE 3 OR 4 IDH-MUTANT GLIOMAS

Authors
Category Primary study
Conference7th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies, WFNOS and 30th Society for Neuro-Oncology Annual Meeting, SNO
Year 2025
This article has no abstract
Epistemonikos ID: 6eae3b6dfc5af705ed56c855a93feb1278a41a6a
First added on: Dec 12, 2025